Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma

The majority of patients with refractory, advanced-stage mycosis fungoides (MF) or Sézary syndrome (SS) have a life expectancy of <5 years. Here, we report a phase 2 study of a novel nonmyeloablative allogeneic transplantation strategy tailored for this patient population. This study has complete...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood Adv
Päätekijät: Weng, Wen-Kai, Arai, Sally, Rezvani, Andrew, Johnston, Laura, Lowsky, Robert, Miklos, David, Shizuru, Judith, Muffly, Lori, Meyer, Everett, Negrin, Robert S., Wang, Erica, Almazan, Timothy, Million, Lynn, Khodadoust, Michael, Li, Shufeng, Hoppe, Richard T., Kim, Youn H.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2020
Aiheet:
Clinical Trials and Observations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509879/
https://ncbi.nlm.nih.gov/pubmed/32941647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001627
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia